Vident Advisory LLC Has $3.45 Million Stake in Colgate-Palmolive (NYSE:CL)

Vident Advisory LLC boosted its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 89.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 37,994 shares of the company's stock after acquiring an additional 17,919 shares during the quarter. Vident Advisory LLC's holdings in Colgate-Palmolive were worth $3,454,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Chicago Partners Investment Group LLC grew its stake in Colgate-Palmolive by 16.2% during the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company's stock worth $591,000 after buying an additional 943 shares during the last quarter. Aviva PLC grew its stake in Colgate-Palmolive by 13.4% during the fourth quarter. Aviva PLC now owns 973,421 shares of the company's stock worth $88,494,000 after buying an additional 114,855 shares during the last quarter. Impact Partnership Wealth LLC bought a new stake in Colgate-Palmolive during the fourth quarter worth about $803,000. Barclays PLC grew its stake in Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after buying an additional 2,132,747 shares during the last quarter. Finally, Atlas Legacy Advisors LLC bought a new stake in Colgate-Palmolive during the fourth quarter worth about $311,000. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Trading Up 1.9%

NYSE CL traded up $1.77 during trading hours on Friday, hitting $92.67. The company's stock had a trading volume of 6,723,726 shares, compared to its average volume of 4,669,281. The stock has a fifty day moving average of $91.81 and a 200 day moving average of $91.24. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The firm has a market capitalization of $75.10 billion, a P/E ratio of 26.33, a PEG ratio of 4.20 and a beta of 0.39. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.92 billion. During the same period in the prior year, the business posted $0.86 earnings per share. Colgate-Palmolive's revenue was down 3.0% compared to the same quarter last year. Equities research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th were issued a $0.52 dividend. The ex-dividend date was Thursday, April 17th. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a yield of 2.24%. Colgate-Palmolive's dividend payout ratio (DPR) is 58.76%.

Colgate-Palmolive announced that its board has authorized a stock buyback program on Thursday, March 20th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the company to repurchase up to 6.8% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's board believes its stock is undervalued.

Analyst Ratings Changes

CL has been the topic of several research analyst reports. JPMorgan Chase & Co. upped their price objective on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research note on Monday, April 28th. Barclays decreased their price target on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a research note on Friday, April 11th. Raymond James reissued an "outperform" rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Wells Fargo & Company increased their price target on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research note on Wednesday, April 2nd. Finally, Citigroup increased their price target on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research note on Monday, April 28th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have given a buy rating to the company's stock. According to data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of "Hold" and a consensus target price of $102.12.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.